Rafferty Asset Management LLC Acquires 1,417 Shares of DENTSPLY SIRONA Inc (XRAY)

Rafferty Asset Management LLC boosted its position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 8.5% during the first quarter, Holdings Channel reports. The fund owned 18,176 shares of the medical instruments supplier’s stock after buying an additional 1,417 shares during the period. Rafferty Asset Management LLC’s holdings in DENTSPLY SIRONA were worth $1,135,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in the company. Howard Hughes Medical Institute increased its position in shares of DENTSPLY SIRONA by 134.9% in the first quarter. Howard Hughes Medical Institute now owns 2,751 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 1,580 shares during the last quarter. Penserra Capital Management LLC increased its position in shares of DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 240 shares during the last quarter. Perennial Advisors LLC purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter worth approximately $185,000. Howland Capital Management LLC purchased a new position in shares of DENTSPLY SIRONA during the first quarter worth approximately $203,000. Finally, Focused Wealth Management Inc increased its position in shares of DENTSPLY SIRONA by 179.2% in the fourth quarter. Focused Wealth Management Inc now owns 4,051 shares of the medical instruments supplier’s stock worth $234,000 after buying an additional 2,600 shares during the last quarter. Institutional investors own 94.32% of the company’s stock.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

DENTSPLY SIRONA Inc (NASDAQ XRAY) traded up 0.25% during trading on Friday, hitting $63.61. 347,121 shares of the stock were exchanged. The company has a market cap of $14.58 billion, a price-to-earnings ratio of 40.93 and a beta of 1.21. The stock’s 50 day moving average is $63.15 and its 200-day moving average is $60.92. DENTSPLY SIRONA Inc has a one year low of $55.00 and a one year high of $65.83.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Tuesday, May 9th. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by $0.01. DENTSPLY SIRONA had a net margin of 6.63% and a return on equity of 2.95%. The company had revenue of $900.50 million during the quarter, compared to the consensus estimate of $916.55 million. During the same quarter last year, the company earned $0.69 earnings per share. The business’s revenue was up 16.6% on a year-over-year basis. On average, equities research analysts expect that DENTSPLY SIRONA Inc will post $2.84 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece was reported by Mideast Time and is the sole property of of Mideast Time. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.mideasttime.com/rafferty-asset-management-llc-acquires-1417-shares-of-dentsply-sirona-inc-xray/1766686.html.

A number of equities analysts have commented on the stock. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Thursday, March 30th. Barrington Research downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Tuesday, February 21st. Cleveland Research upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research report on Tuesday, May 23rd. Goldman Sachs Group Inc downgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and cut their price objective for the stock from $60.00 to $55.00 in a research report on Tuesday, May 23rd. Finally, Stifel Nicolaus upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and upped their price objective for the stock from $62.00 to $70.00 in a research report on Monday, February 13th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the company. DENTSPLY SIRONA has a consensus rating of “Buy” and a consensus price target of $66.80.

In other DENTSPLY SIRONA news, CEO Christopher T. Clark sold 89,700 shares of the business’s stock in a transaction on Friday, April 7th. The stock was sold at an average price of $62.67, for a total value of $5,621,499.00. Following the transaction, the chief executive officer now owns 112,067 shares of the company’s stock, valued at $7,023,238.89. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO James G. Mosch sold 50,600 shares of the business’s stock in a transaction on Monday, April 24th. The stock was sold at an average price of $63.49, for a total value of $3,212,594.00. Following the completion of the transaction, the chief executive officer now directly owns 105,083 shares in the company, valued at approximately $6,671,719.67. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:XRAY”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Receive News & Ratings for DENTSPLY SIRONA Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.